Bristol Myers Squibb (BMY) announces Phase 3 ALOFT-IPF trial evaluating admilparant in adults with idiopathic pulmonary fibrosis met primary endpoint
Newsquawk Staff ·
Bristol Myers Squibb (BMY) announces Phase 3 ALOFT-IPF trial evaluating admilparant in adults with idiopathic pulmonary fibrosis met primary endpoint.
What it means
Positive Phase 3 readouts in idiopathic pulmonary fibrosis sit in a category with a thin precedent set: only two antifibrotics have historically secured approval in this indication, and both decelerate decline rather than reverse it, so any agent hitting its primary endpoint on lung function or progression immediately enters a small competitive field. The pattern in comparable late-stage respiratory and fibrosis wins has been a sharp single-name move on the day, with the durability of the re-rating hinging on the secondary endpoints, the safety discontinuation rate, and whether the magnitude of effect clears the bar set by the standard of care rather than merely reaching statistical significance. The distinction that matters here is between a trial designed to support filing on its own and one positioned as confirmatory; press-release language around whether the programme proceeds to regulatory submission is the tell. Watch next for full data at a medical congress, since topline press releases in past episodes of this kind have occasionally been revised in interpretation once complete datasets, subgroup performance, and adverse event detail are visible. For Bristol Myers specifically, pipeline successes have historically been weighed against its looming patent-exposure narrative, so the follow-on question is whether this asset is sized to offset that gap. Peer read-across to other IPF and fibrosis developers is the standard second-order trade in such episodes.
Sources
- Microsoft (MSFT) on the outage says it addressed the underlying issue and continue to restore service to remaining customers and regions
- OpenAI starts ChatGPT wallet, available to Pro subscribers, CNBC reports
- Merck (MRK) says WELIREG in combination with lenvatinib demonstrated a statistically significant and clinically meaningful improvement in progression-free survival, one of the study's dual primary endpoints, for treatment of ccRCC
- EUROPEAN OPEN: CFR SW H1 op profit up sharply; BC8 GY raises EBT outlook; AMS SW Q3 revenue miss; BOSS GY appoints new CEO; STLAM IM faces potential Canada lawsuit; CARLB DC plans USD 600mln India IPO
- US Market Wrap: Stocks hit on Huang exit and crude jumps on fading US/Iran deal hopes
Related headlines
- Newsquawk European Market Wrap - 13th November 20262 hours ago
- US EQUITY OPEN: Indices pare gains as Tech once again underperforms2 hours ago
- Daily US Equity Opening News: MSFT outage recovery continues; ANT IPO 6x oversubscribed; NSCL needs more financing for ANT deal3 hours ago
- US Broker Moves: PANW upgraded at KeyBanc; AVGO downgraded at Rothschild Redburn3 hours ago
- Microsoft (MSFT), speaking on the outage, says that "we are seeing positive results for service stability and increased capacity as a result of our latest optimisation actions" 9 hours ago
- Japan's Ministry of Finance says it can't receive emails due to the Microsoft (MSFT) outage11 hours ago
- Cisco Systems Inc. (CSCO) Q1 2027 (USD) Adj. EPS 1.40 (exp. 1.33), Revenue 18.50bln (exp. 18.13bln)19 hours ago
- Applied Materials Inc. (AMAT) Q4 FY26 (USD): Adj. EPS 4.16 (exp. 4.06), Revenue 10.4bln (exp. 10.3bln)20 hours ago
- Nvidia (NVDA) plans to keep investigating former CEO Huang’s possible involvement with a person alleged to be a Chinese spy, according to The Information, citing a person familiar with the matter20 hours ago
- New York qualifies NextEra (NEE) for a possible nuclear partnership20 hours ago
- Microsoft (MSFT), on the outage, says recovery keeps progressing across affected regions, with wider improvements now seen in North America and much of Europe4 hours ago
- US President Trump is reportedly push Southeast Asian countries to join Pax Silica at ASEAN summit, SCMP reports1 hour ago
- Newsquawk Weekly Economic Release 16th - 20th November 20262 hours ago
- Some of US President Trump's advisers have discussed whether Commerce Secretary Lutnick should be dismissed, reports CNN citing sources; Trump has also received calls from officials and outside advisers raising concerns about Lutnick3 hours ago
- German Chancellor Merz says his message to the US before US President Trump meets Russian President Putin is ‘no surprises please’4 hours ago